Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
The global Platelet Rich Plasma market was valued at US$ 295 million in 2023 and is anticipated to reach US$ 342.2 million by 2030, witnessing a CAGR of 2.1% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Platelet Rich Plasma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet Rich Plasma.
Report Scope
The Platelet Rich Plasma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platelet Rich Plasma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platelet Rich Plasma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Platelet Rich Plasma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet Rich Plasma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 P-PRP
1.2.3 L-PRP
1.2.4 L-PRF
1.3 Market by Application
1.3.1 Global Platelet Rich Plasma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Orthopedic Surgery
1.3.3 Cosmetic Surgery
1.3.4 General Surgery
1.3.5 Other Surgeries
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Platelet Rich Plasma Market Perspective (2019-2030)
2.2 Platelet Rich Plasma Growth Trends by Region
2.2.1 Global Platelet Rich Plasma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Platelet Rich Plasma Historic Market Size by Region (2019-2024)
2.2.3 Platelet Rich Plasma Forecasted Market Size by Region (2025-2030)
2.3 Platelet Rich Plasma Market Dynamics
2.3.1 Platelet Rich Plasma Industry Trends
2.3.2 Platelet Rich Plasma Market Drivers
2.3.3 Platelet Rich Plasma Market Challenges
2.3.4 Platelet Rich Plasma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet Rich Plasma Players by Revenue
3.1.1 Global Top Platelet Rich Plasma Players by Revenue (2019-2024)
3.1.2 Global Platelet Rich Plasma Revenue Market Share by Players (2019-2024)
3.2 Global Platelet Rich Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Platelet Rich Plasma Revenue
3.4 Global Platelet Rich Plasma Market Concentration Ratio
3.4.1 Global Platelet Rich Plasma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet Rich Plasma Revenue in 2023
3.5 Platelet Rich Plasma Key Players Head office and Area Served
3.6 Key Players Platelet Rich Plasma Product Solution and Service
3.7 Date of Enter into Platelet Rich Plasma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet Rich Plasma Breakdown Data by Type
4.1 Global Platelet Rich Plasma Historic Market Size by Type (2019-2024)
4.2 Global Platelet Rich Plasma Forecasted Market Size by Type (2025-2030)
5 Platelet Rich Plasma Breakdown Data by Application
5.1 Global Platelet Rich Plasma Historic Market Size by Application (2019-2024)
5.2 Global Platelet Rich Plasma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Platelet Rich Plasma Market Size (2019-2030)
6.2 North America Platelet Rich Plasma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Platelet Rich Plasma Market Size by Country (2019-2024)
6.4 North America Platelet Rich Plasma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Platelet Rich Plasma Market Size (2019-2030)
7.2 Europe Platelet Rich Plasma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Platelet Rich Plasma Market Size by Country (2019-2024)
7.4 Europe Platelet Rich Plasma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Platelet Rich Plasma Market Size (2019-2030)
8.2 Asia-Pacific Platelet Rich Plasma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Platelet Rich Plasma Market Size by Region (2019-2024)
8.4 Asia-Pacific Platelet Rich Plasma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Platelet Rich Plasma Market Size (2019-2030)
9.2 Latin America Platelet Rich Plasma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Platelet Rich Plasma Market Size by Country (2019-2024)
9.4 Latin America Platelet Rich Plasma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet Rich Plasma Market Size (2019-2030)
10.2 Middle East & Africa Platelet Rich Plasma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Platelet Rich Plasma Market Size by Country (2019-2024)
10.4 Middle East & Africa Platelet Rich Plasma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Harvest Technologies
11.1.1 Harvest Technologies Company Detail
11.1.2 Harvest Technologies Business Overview
11.1.3 Harvest Technologies Platelet Rich Plasma Introduction
11.1.4 Harvest Technologies Revenue in Platelet Rich Plasma Business (2019-2024)
11.1.5 Harvest Technologies Recent Development
11.2 DePuy Synthes
11.2.1 DePuy Synthes Company Detail
11.2.2 DePuy Synthes Business Overview
11.2.3 DePuy Synthes Platelet Rich Plasma Introduction
11.2.4 DePuy Synthes Revenue in Platelet Rich Plasma Business (2019-2024)
11.2.5 DePuy Synthes Recent Development
11.3 Stryker
11.3.1 Stryker Company Detail
11.3.2 Stryker Business Overview
11.3.3 Stryker Platelet Rich Plasma Introduction
11.3.4 Stryker Revenue in Platelet Rich Plasma Business (2019-2024)
11.3.5 Stryker Recent Development
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Detail
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Platelet Rich Plasma Introduction
11.4.4 Zimmer Biomet Revenue in Platelet Rich Plasma Business (2019-2024)
11.4.5 Zimmer Biomet Recent Development
11.5 Arthrex
11.5.1 Arthrex Company Detail
11.5.2 Arthrex Business Overview
11.5.3 Arthrex Platelet Rich Plasma Introduction
11.5.4 Arthrex Revenue in Platelet Rich Plasma Business (2019-2024)
11.5.5 Arthrex Recent Development
11.6 Exactech
11.6.1 Exactech Company Detail
11.6.2 Exactech Business Overview
11.6.3 Exactech Platelet Rich Plasma Introduction
11.6.4 Exactech Revenue in Platelet Rich Plasma Business (2019-2024)
11.6.5 Exactech Recent Development
11.7 Emcyte Corporation
11.7.1 Emcyte Corporation Company Detail
11.7.2 Emcyte Corporation Business Overview
11.7.3 Emcyte Corporation Platelet Rich Plasma Introduction
11.7.4 Emcyte Corporation Revenue in Platelet Rich Plasma Business (2019-2024)
11.7.5 Emcyte Corporation Recent Development
11.8 Arteriocyte
11.8.1 Arteriocyte Company Detail
11.8.2 Arteriocyte Business Overview
11.8.3 Arteriocyte Platelet Rich Plasma Introduction
11.8.4 Arteriocyte Revenue in Platelet Rich Plasma Business (2019-2024)
11.8.5 Arteriocyte Recent Development
11.9 Adilyfe
11.9.1 Adilyfe Company Detail
11.9.2 Adilyfe Business Overview
11.9.3 Adilyfe Platelet Rich Plasma Introduction
11.9.4 Adilyfe Revenue in Platelet Rich Plasma Business (2019-2024)
11.9.5 Adilyfe Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research